Anika Reports Third Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
Anika Therapeutics (ANIK) Tops Q3 EPS by 25c
October 24, 2019 4:36 PM EDTAnika Therapeutics (NASDAQ: ANIK) reported Q3 EPS of $0.64, $0.25 better than the analyst estimate of $0.39. Revenue for the quarter came in at $29.7 million versus the consensus estimate of $27.01 million.
Anika delivered double-digit revenue and earnings growth in the third quarter on the strength of growing global demand, Anikas expanding commercial platform, and... More
